Atossa Genetics Retained Earnings (Accumulated Deficit) 2012-2024 | ATOS
Atossa Genetics retained earnings (accumulated deficit) from 2012 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Atossa Genetics Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-212 |
| 2023 | $-186 |
| 2022 | $-156 |
| 2021 | $-129 |
| 2020 | $-112 |
| 2019 | $-94 |
| 2018 | $-77 |
| 2017 | $-65 |
| 2016 | $-57 |
| 2015 | $-51 |
| 2014 | $-35 |
| 2013 | $-21 |
| 2012 | $-10 |
| 2011 | $-5 |
| Atossa Genetics Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-212 |
| 2024-09-30 | $-205 |
| 2024-06-30 | $-198 |
| 2024-03-31 | $-192 |
| 2023-12-31 | $-186 |
| 2023-09-30 | $-179 |
| 2023-06-30 | $-172 |
| 2023-03-31 | $-162 |
| 2022-12-31 | $-156 |
| 2022-09-30 | $-149 |
| 2022-06-30 | $-141 |
| 2022-03-31 | $-134 |
| 2021-12-31 | $-129 |
| 2021-09-30 | $-124 |
| 2021-06-30 | $-119 |
| 2021-03-31 | $-112 |
| 2020-12-31 | $-112 |
| 2020-09-30 | $-104 |
| 2020-06-30 | $-101 |
| 2020-03-31 | $-97 |
| 2019-12-31 | $-94 |
| 2019-09-30 | $-91 |
| 2019-06-30 | $-88 |
| 2019-03-31 | $-81 |
| 2018-12-31 | $-77 |
| 2018-09-30 | $-75 |
| 2018-06-30 | $-71 |
| 2018-03-31 | $-67 |
| 2017-12-31 | $-65 |
| 2017-09-30 | $-63 |
| 2017-06-30 | $-61 |
| 2017-03-31 | $-59 |
| 2016-12-31 | $-57 |
| 2016-09-30 | $-55 |
| 2016-06-30 | $-55 |
| 2016-03-31 | $-53 |
| 2015-12-31 | $-51 |
| 2015-09-30 | $-46 |
| 2015-06-30 | $-42 |
| 2015-03-31 | $-39 |
| 2014-12-31 | $-35 |
| 2014-09-30 | $-29 |
| 2014-06-30 | $-26 |
| 2014-03-31 | $-23 |
| 2013-12-31 | $-21 |
| 2013-09-30 | $-18 |
| 2013-06-30 | $-14 |
| 2013-03-31 | $-12 |
| 2012-12-31 | $-10 |
| 2012-09-30 | $-8 |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.115B | $0.000B |
| Atossa Genetics Inc. is a healthcare company focused on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer. The Company's diagnostic tests consist of medical devices which can collect fluid samples from the breast milk ducts. It is also conducting research on the treatment of pre-cancerous cells by using its FDA-cleared microcatheters to deliver, directly into the milk ducts, anti-cancer drugs that can be used to treat the pre-cancerous lesions. Atossa Genetics Inc. is headquartered in Seattle, WA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $202.130B | 88.53 |
| Thermo Fisher Scientific (TMO) | United States | $161.926B | 19.59 |
| Alcon (ALC) | Switzerland | $45.995B | 31.08 |
| Edwards Lifesciences (EW) | United States | $44.288B | 29.04 |
| IDEXX Laboratories (IDXX) | United States | $40.945B | 47.06 |
| DexCom (DXCM) | United States | $32.980B | 50.98 |
| IQVIA Holdings (IQV) | United States | $26.068B | 14.60 |
| Mettler-Toledo (MTD) | United States | $24.462B | 29.09 |
| STERIS (STE) | Ireland | $22.711B | 25.97 |
| Waters (WAT) | United States | $21.365B | 30.14 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.057B | 0.00 |
| Hologic (HOLX) | United States | $12.729B | 13.83 |
| Sysmex ADR (SSMXY) | Japan | $11.601B | 0.00 |
| Penumbra (PEN) | United States | $11.465B | 89.99 |
| Masimo (MASI) | United States | $8.760B | 32.31 |
| Globus Medical (GMED) | United States | $8.012B | 18.79 |
| Teleflex (TFX) | United States | $5.603B | 9.25 |
| Glaukos (GKOS) | United States | $5.278B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.222B | 22.12 |
| TransMedics (TMDX) | United States | $4.130B | 89.79 |
| PROCEPT BioRobotics (PRCT) | United States | $2.935B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.402B | 14.31 |
| Veracyte (VCYT) | United States | $2.295B | 32.21 |
| Nihon Kohden (NHNKY) | Japan | $2.030B | 23.28 |
| Elekta AB (EKTAY) | Sweden | $2.018B | 18.14 |
| Alphatec Holdings (ATEC) | United States | $1.859B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.541B | 0.00 |
| Artivion (AORT) | United States | $1.235B | 115.64 |
| Pulse Biosciences (PLSE) | United States | $1.133B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.050B | 5.58 |
| OPKO Health (OPK) | United States | $1.031B | 0.00 |
| SiBone (SIBN) | United States | $0.792B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.690B | 15.08 |
| IRadimed (IRMD) | United States | $0.677B | 34.34 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.588B | 9.14 |
| Beta Bionics (BBNX) | United States | $0.572B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.564B | 0.00 |
| RxSight (RXST) | United States | $0.536B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.532B | 0.00 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.487B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.439B | 0.00 |
| NeuroPace (NPCE) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.397B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.352B | 10.89 |
| Pacific Biosciences Of California (PACB) | United States | $0.345B | 0.00 |
| Neuronetics (STIM) | United States | $0.293B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.91 |
| Alpha Tau Medical (DRTS) | Israel | $0.194B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| 908 Devices (MASS) | United States | $0.166B | 0.00 |
| Inogen (INGN) | United States | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.164B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| CVRx (CVRX) | United States | $0.142B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.125B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 11.48 |
| InspireMD (NSPR) | Israel | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.061B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 15.25 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.00 |